Efavirenz
Efavirenz is listed in the FDA National Drug Code directory with 21 NDC codes, marketed under brand name including Efavirenz. Available dosage forms: capsule, powder, tablet, film coated, tablet.
Drug Details
- Generic Name
- Efavirenz
- Brand Names
- Efavirenz
- Application Number
- ANDA078064
- Sponsor
- Aurobindo Pharma Limited
- NDC Codes
- 21
- Dosage Forms
- CAPSULE, POWDER, TABLET, FILM COATED, TABLET
- Routes
- ORAL
- Active Ingredients
- EFAVIRENZ
Indications and Usage
1 INDICATIONS AND USAGE Efavirenz tablets in combination with other antiretroviral agents are indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and in pediatric patients at least 3 months old and weighing at least 3.5 kg. Efavirenz is a non-nucleoside reverse transcriptase inhibitor indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 infection in adults and in pediatric patients at least 3 months old and weighing at least 3.5 kg. ( 1 )